Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

Patent metadata

Field	Value
Publication number	US-9598355-B2
Application number	US-201414510603-A
Country	US
Kind code	B2
Filing date	Oct 9, 2014
Priority date	May 29, 2007
Publication date	Mar 21, 2017
Grant date	Mar 21, 2017

Abstract

The present invention provides diacylhydrazine ligands and chiral diacylhydrazine ligands for use with ecdysone receptor-based inducible gene expression systems. Thus, the present invention is useful for applications such as gene therapy, large scale production of proteins and antibodies, cell-based screening assays, functional genomics, proteomics, metabolomics, and regulation of traits in transgenic organisms, where control of gene expression levels is desirable. An advantage of the present invention is that it provides a means to regulate gene expression and to tailor expression levels to suit the user's requirements.

First claim

What is claimed is:

1. A method of modulating the expression of a gene of interest in a host cell, wherein the host cell comprises a first recombinant gene expression cassette comprising a first polynucleotide encoding a first polypeptide comprising:
i) a DNA-binding domain; and
ii) a Group H nuclear receptor ligand binding domain;

and a second recombinant gene expression cassette comprising:
i) a response element capable of binding to said DNA binding domain;
ii) a promoter; and
iii) said gene of interest;

the method comprising contacting said host cell with a compound selected from the group consisting of:
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-ethyl-3-methoxy-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N′-benzoyl-N-(1-tert-butyl-butyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-methyl-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-fluoro-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N′-(2-bromo-benzoyl)-N-(1-tert-butyl-butyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(3-methyl-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(4-methyl-benzoyl)-hydrazide; and
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(3-methoxy-2-methyl-benzoyl)-hydrazide,
wherein the expression of the gene of interest is modulated.

2. A method of modulating the expression of a gene in a host cell comprising the steps of:
(a) introducing into the host cell a gene expression modulation system comprising:
(i) a first recombinant gene expression cassette that is capable of being expressed in a host cell, said first recombinant gene expression cassette comprising a polynucleotide sequence that encodes a first hybrid polypeptide comprising:
(a) a DNA-binding domain that recognizes a response element associated with a gene whose expression is to be modulated; and
(b) an ecdysone receptor ligand binding domain;

(ii) a second recombinant gene expression cassette that is capable of being expressed in the host cell, said second recombinant gene expression cassette comprising a polynucleotide sequence that encodes a second hybrid polypeptide comprising:
(a) a transactivation domain; and
(b) a chimeric retinoid X receptor ligand binding domain; and

(iii) a third recombinant gene expression cassette that is capable of being expressed in a host cell, said third recombinant gene expression cassette comprising a polynucleotide sequence comprising:
(a) a response element recognized by the DNA-binding domain of the first hybrid polypeptide;
(b) a promoter that is activated by the transactivation domain of the second hybrid polypeptide; and
(c) a gene whose expression is to be modulated; and

(b) contacting the host cell with a compound selected from the group consisting of:
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-ethyl-3-methoxy-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N′-benzoyl-N-(1-tert-butyl-butyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-methyl-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-fluoro-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N′-(2-bromo-benzoyl)-N-(1-tert-butyl-butyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(3-methyl-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(4-methyl-benzoyl)-hydrazide; and
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(3-methoxy-2-methyl-benzoyl)-hydrazide,
wherein the expression of the gene in the host cell is modulated.

3. A method for producing a polypeptide comprising the steps of:
(a) selecting a host cell which is substantially insensitive to exposure to a compound selected from the group consisting of:
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-ethyl-3-methoxy-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N′-benzoyl-N-(1-tert-butyl-butyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-methyl-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-fluoro-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N′-(2-bromo-benzoyl)-N-(1-tert-butyl-butyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(3-methyl-benzoyl)-hydrazide;
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(4-methyl-benzoyl)-hydrazide; or
(R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(3-methoxy-2-methyl-benzoyl)-hydrazide,

(b) introducing into the host cell:
(1) a DNA construct comprising:
(a) an exogenous gene encoding the polypeptide; and
(b) a response element;

wherein the exogenous gene is under the control of the response element; and
(ii) an ecdysone receptor complex comprising:
(a) a DNA binding domain that binds to the response element;
(b) a binding domain for said compound; and
(c) a transactivation domain; and

(c) exposing the cell to said compound; wherein a polypeptide is produced.

4. The method of claim 1 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-ethyl-3-methoxy-benzoyl)-hydrazide.

5. The method of claim 1 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-methyl-benzoyl)-hydrazide.

6. The method of claim 1 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-fluoro-benzoyl)-hydrazide.

7. The method of claim 1 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(4-methyl-benzoyl)-hydrazide.

8. The method of claim 1 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(3-methoxy-2-methyl-benzoyl)-hydrazide.

9. The method of claim 2 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-ethyl-3-methoxy-benzoyl)-hydrazide.

10. The method of claim 2 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N-(2-methyl-benzoyl)-hydrazide.

11. The method of claim 2 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-fluoro-benzoyl)-hydrazide.

12. The method of claim 2 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(4-methyl-benzoyl)-hydrazide.

13. The method of claim 2 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(3-methoxy-2-methyl-benzoyl)-hydrazide.

14. The method of claim 3 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N-(2-ethyl-3-methoxy-benzoyl)-hydrazide.

15. The method of claim 3 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-methyl-benzoyl)-hydrazide.

16. The method of claim 3 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(2-fluoro-benzoyl)-hydrazide.

17. The method of claim 3 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tort-butyl-butyl)-N′-(4-methyl-benzoyl)-hydrazide.

18. The method of claim 3 , comprising contacting said host cell with (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N′-(3-methoxy-2-methyl-benzoyl)-hydrazide.

19. The method of claim 1 , wherein said gene of interest is IL-12.

20. The method of claim 2 , wher

Assignees

• Intrexon Corp

Inventors

• Hormann Robert Eugene
• Li Bing

Classifications

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• A61P17/00

  Drugs for dermatological disorders · CPC title

• C07C241/04 Primary

  Preparation of hydrazides · CPC title

• C07D317/68

  Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen · CPC title